Print

PerkinElmer, Inc. (PKI) Launches New Epigenetic Cellular Detection Research Kits at its Revolutionaries for Global Health Summit  
11/5/2012 9:59:50 AM

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of a panel of nine new epigenetic research assay kits for the detection of endogenous histone modifications at the Revolutionaries for Global Health Summit (RGH), a global scientific community event dedicated to advancing personalized health. Last week’s RGH Summit in San Francisco, is part of a global series hosted by PerkinElmer to share advanced research and foster collaboration among researchers and practitioners as they deploy PerkinElmer’s disruptive technologies and approaches to support research to prevent, detect, and treat disease.
//-->